Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

James Eshleman Lab: Targeting somatic PAMs by CRISPR/Cas9 causes delayed cancer cell death

Unpublished

Plasmids from Article

ID Plasmid Purpose
193780pLentiCas9-T2A-mAppleTricistronic expression of Cas9-mApple-BSD in mammalian cells
193781pLenti-dCas9-T2A-GFPTricistronic expression of dCas9-EGFP-BSD

Antibodies from Article